In the US, influenza vaccine was effective to prevent A(H3N2) influenza presenting VE of 43% (95% CI, 29 to 54) in overall aged population, however, in 18–49 years and ≥65 years age group, protection did not reach statistical significance with wide range of confidence interval [ 10 ].
← all excerpts
Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.
1
—
—